一个CD1c脂质无意识的T细胞受体双特异性参与者将T细胞重定向对抗CD1c+细胞
Rita Szoke-Kovacs1,2, Sophie Khakoo1, Victor Lopes Rangel1
1Experimental Immunology, Immunocore Ltd, Abingdon, United Kingdom.
Frontiers in immunology
|August 8, 2025
概括
研究人员开发了一种针对CD1c的新型免疫疗法,CD1c是一种在某些免疫细胞上发现的分子. 这种方法,使用T细胞受体 (TCR) 双特异性参与者,显示出治疗CD1c+白血病的前景,并减少副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 免疫疗法为传统疗法提供了一个有前途的癌症治疗替代方案.
- 癌细胞表面标记物是常见的免疫疗法点,但通常受患者遗传学限制.
- CD1c是一种非多态抗原呈现分子,表达在特定的造血细胞上,呈现出潜在的通用标.
研究的目的:
- 研究CD1c作为一种潜在的免疫治疗点,减少了瘤外毒性.
- 识别和描述识别CD1c.的T细胞受体 (TCRs) 的T细胞受体.
- 开发用于CD1c向癌症治疗的新型双特异性参与者.
主要方法:
- 确定了一种T细胞受体 (TCR),该受体能够独立于脂质识别CD1c.
- 确定TCR-CD1c复合体的晶体结构,以阐明结合机制.
- 产生了亲和度增强的TCR变体,并将它们与抗CD3抗体融合在一起,用于T细胞重定向.
- 进行了脂质组分析,以了解CD1c-TCR相互作用.
主要成果:
- 该TCR-CD1c复杂结构揭示了一个新的自身抗原识别机制和脂质结合区域的灵活性.
- 亲和度增强的TCR变体显示CD1c的不规则的脂质识别,有利于更大的脂质头组.
- 由此产生的双特异分子有效诱导T细胞介导的CD1c阳性癌症细胞系的杀死.
结论:
- CD1c是开发免疫疗法的一个可行的标,具有较低的瘤外毒性风险.
- 针对CD1c的TCR双特异性参与者代表了非MHC受限,通用癌症治疗的潜在策略.
- 这些发现支持开发针对CD1c+白血病的CD1c向疗法.
相关概念视频
01:22T Cell Activation and Clonal Selection
4.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.7K
01:27Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
01:28Diversity of Antigen Receptors
799
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
799